How do you approach a cervical node biopsy-proven follicular lymphoma in situ in a symptomatic patient with night sweats and PET findings of low SUV uptake throughout the body?

Topics: Hematologic Malignancies • Medical Oncology • Lymphoma • Hematology

Would you biopsy another site or treat the patient?

Answer from: Medical Oncologist at Academic Institution

Follicular lymphoma in situ, aka in situ follicular neoplasm (ISFN) is an uncommon entity, representing an early precursor lesion and better conceived of as premalignant as opposed to a true malignancy, and a pathologic diagnosis of ISFN is not an indication for therapy. Most patients with ISFN will...

Comments

Medical Oncologist at GW CANCER CENTER
Agree with Dr. @Matasar. Assuming this was an exci...

Related Questions